35,180
Participants
Start Date
February 1, 2021
Primary Completion Date
March 30, 2021
Study Completion Date
March 30, 2021
RNA vaccine
We elicit subjects' willingness to receive RNA COVID-19 vaccine
20% adoption rate
We elicit subjects' willingness to receive the new vaccine if 20% of the country's population has received it
40% adoption rate
We elicit subjects' willingness to receive the new vaccine if 40% of the country's population has received it
60% adoption rate
We elicit subjects' willingness to receive the new vaccine if 60% of the country's population has received it
80% adoption rate
We elicit subjects' willingness to receive the new vaccine if 80% of the country's population has received it
Conventional vaccine
We elicit subjects' willingness to receive conventional COVID-19 vaccine
0% adoption rate
We elicit subjects' willingness to receive the new vaccine if 0% of the country's population has received it
SurveyMonkey, San Mateo
National University of Singapore
OTHER